AHA Advises Oral, Not Injectable, Penicillin to Treat High-Risk Rheumatic Heart Disease
January 21st 2022In a presidential advisory, the American Heart Association says that individuals thought to be having an allergic response to the injection may instead by experiencing a cardiac reaction.
Read More
The Mechanism of Action of Inclisiran for LDL-C Management in ASCVD
January 21st 2022Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discussed inclisiran’s mechanism of action and how it supports LDL-C management for patients with ASCVD.
Watch
Outlook for Health System-Based Specialty Pharmacy in 2022 and Beyond
January 20th 2022With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Read More